 | Up a level |
Journal Article
Al-Sawaf, Othman 
ORCID: 0000-0001-9895-0570, Zhang, Can ORCID: 0000-0001-5459-5298, Jin, Hyun Yong, Robrecht, Sandra ORCID: 0000-0001-8848-6655, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria ORCID: 0000-0002-7669-7890, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Frenzel, Lukas P. ORCID: 0009-0006-5927-4825, Peifer, Martin ORCID: 0000-0002-5243-5503, Eichhorst, Barbara ORCID: 0000-0001-9990-6918, Stilgenbauer, Stephan ORCID: 0000-0002-6830-9296, Jiang, Yanwen, Hallek, Michael ORCID: 0000-0002-7425-4455 and Fischer, Kirsten ORCID: 0009-0006-6169-9152
(2023).
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Nature Communications, 14 (1).
p. 2147.
Springer Nature.
ISSN 2041-1723
